Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
CBLL 12.23.2024
Date of Upcoming Event:2025-01-13
Name of Upcoming Event:43rd Annual J.P. Morgan Healthcare Conference
SUNNYVALE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming 43rdAnnual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 13, 2025, at 7:30 a.m. Pacific Standard Time.
Event: 43rdAnnual J.P. Morgan Healthcare ConferenceDate: Monday, January 13, 2025Time: 7:30 a.m. PST
A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website athttps://investors.ceribell.com/.
About Ceribell, Inc.Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA 510(k) cleared for indicating suspected seizure activity and currently utilized in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California. For more information, please visitwww.ceribell.comor follow the company onLinkedIn.
Investor ContactBrian Johnston or Laine MorganGilmartin GroupInvestors@ceribell.com
Media ContactCorrie RosePress@ceribell.com
